Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Gynecology

  Free Subscription


Articles published in Oncogene

Retrieve available abstracts of 28 articles:
HTML format



Single Articles


    November 2021
  1. YIN L, Zeng Y, Zeng R, Chen Y, et al
    Protein kinase RNA-activated controls mitotic progression and determines paclitaxel chemosensitivity through B-cell lymphoma 2 in ovarian cancer.
    Oncogene. 2021 Nov 19. pii: 10.1038/s41388-021-02117.
    PubMed     Abstract available


  2. BOUDHRAA Z, Zaoui K, Fleury H, Cahuzac M, et al
    NR1D1 regulation by Ran GTPase via miR4472 identifies an essential vulnerability linked to aneuploidy in ovarian cancer.
    Oncogene. 2021 Nov 6. pii: 10.1038/s41388-021-02082.
    PubMed     Abstract available


    September 2021
  3. MOSKOVICH D, Finkelshtein Y, Alfandari A, Rosemarin A, et al
    Targeting the DIO3 enzyme using first-in-class inhibitors effectively suppresses tumor growth: a new paradigm in ovarian cancer treatment.
    Oncogene. 2021 Sep 23. pii: 10.1038/s41388-021-02020.
    PubMed     Abstract available


  4. FENG Q, Li S, Ma HM, Yang WT, et al
    LGR6 activates the Wnt/beta-catenin signaling pathway and forms a beta-catenin/TCF7L2/LGR6 feedback loop in LGR6(high) cervical cancer stem cells.
    Oncogene. 2021 Sep 6. pii: 10.1038/s41388-021-02002.
    PubMed     Abstract available


    August 2021
  5. LI H, Qi Z, Niu Y, Yang Y, et al
    FBP1 regulates proliferation, metastasis, and chemoresistance by participating in C-MYC/STAT3 signaling axis in ovarian cancer.
    Oncogene. 2021 Aug 6. pii: 10.1038/s41388-021-01957.
    PubMed     Abstract available


    July 2021
  6. FARES B, Berger L, Bangiev-Girsh E, Kakun RR, et al
    PAX8 plays an essential antiapoptotic role in uterine serous papillary cancer.
    Oncogene. 2021 Jul 9. pii: 10.1038/s41388-021-01925.
    PubMed     Abstract available


  7. LI Y, Fei H, Lin Q, Liang F, et al
    ZEB2 facilitates peritoneal metastasis by regulating the invasiveness and tumorigenesis of cancer stem-like cells in high-grade serous ovarian cancers.
    Oncogene. 2021 Jul 1. pii: 10.1038/s41388-021-01913.
    PubMed     Abstract available


    June 2021
  8. ZHANG J, Guan W, Xu X, Wang F, et al
    A novel homeostatic loop of sorcin drives paclitaxel-resistance and malignant progression via Smad4/ZEB1/miR-142-5p in human ovarian cancer.
    Oncogene. 2021 Jun 23. pii: 10.1038/s41388-021-01891.
    PubMed     Abstract available


  9. WU Y, Guo Q, Ju X, Hu Z, et al
    HNRNPH1-stabilized LINC00662 promotes ovarian cancer progression by activating the GRP78/p38 pathway.
    Oncogene. 2021 Jun 19. pii: 10.1038/s41388-021-01884.
    PubMed     Abstract available


  10. WU YH, Huang YF, Chang TH, Chen CC, et al
    COL11A1 activates cancer-associated fibroblasts by modulating TGF-beta3 through the NF-kappaB/IGFBP2 axis in ovarian cancer cells.
    Oncogene. 2021 Jun 11. pii: 10.1038/s41388-021-01865.
    PubMed     Abstract available


    May 2021
  11. TAN J, Zheng X, Li M, Ye F, et al
    C/EBPbeta promotes poly(ADP-ribose) polymerase inhibitor resistance by enhancing homologous recombination repair in high-grade serous ovarian cancer.
    Oncogene. 2021 May 8. pii: 10.1038/s41388-021-01788.
    PubMed     Abstract available


    April 2021
  12. LINDZEN M, Ghosh S, Noronha A, Drago D, et al
    Targeting autocrine amphiregulin robustly and reproducibly inhibits ovarian cancer in a syngeneic model: roles for wildtype p53.
    Oncogene. 2021 Apr 30. pii: 10.1038/s41388-021-01784.
    PubMed     Abstract available


  13. YANG WT, Chen M, Xu R, Zheng PS, et al
    PRDM4 inhibits cell proliferation and tumorigenesis by inactivating the PI3K/AKT signaling pathway through targeting of PTEN in cervical carcinoma.
    Oncogene. 2021 Apr 12. pii: 10.1038/s41388-021-01765.
    PubMed     Abstract available


    March 2021
  14. NI M, Li J, Zhao H, Xu F, et al
    BRD4 inhibition sensitizes cervical cancer to radiotherapy by attenuating DNA repair.
    Oncogene. 2021 Mar 12. pii: 10.1038/s41388-021-01735.
    PubMed     Abstract available


  15. ALI R, Alblihy A, Miligy IM, Alabdullah ML, et al
    Molecular disruption of DNA polymerase beta for platinum sensitisation and synthetic lethality in epithelial ovarian cancers.
    Oncogene. 2021 Mar 5. pii: 10.1038/s41388-021-01710.
    PubMed     Abstract available


    February 2021
  16. MORGAN EL, Patterson MR, Barba-Moreno D, Scarth JA, et al
    The deubiquitinase (DUB) USP13 promotes Mcl-1 stabilisation in cervical cancer.
    Oncogene. 2021 Feb 24. pii: 10.1038/s41388-021-01679.
    PubMed     Abstract available


  17. XING Y, Chen L, Gu H, Yang C, et al
    Downregulation of NUDT21 contributes to cervical cancer progression through alternative polyadenylation.
    Oncogene. 2021 Feb 22. pii: 10.1038/s41388-021-01693.
    PubMed     Abstract available


    January 2021
  18. XIAO Y, Jin L, Deng C, Guan Y, et al
    Inhibition of PFKFB3 induces cell death and synergistically enhances chemosensitivity in endometrial cancer.
    Oncogene. 2021 Jan 8. pii: 10.1038/s41388-020-01621.
    PubMed     Abstract available


  19. YOSHIDA K, Yokoi A, Sugiyama M, Oda S, et al
    Expression of the chrXq27.3 miRNA cluster in recurrent ovarian clear cell carcinoma and its impact on cisplatin resistance.
    Oncogene. 2021 Jan 8. pii: 10.1038/s41388-020-01595.
    PubMed     Abstract available


  20. NOH K, Bach DH, Choi HJ, Kim MS, et al
    The hidden role of paxillin: localization to nucleus promotes tumor angiogenesis.
    Oncogene. 2021;40:384-395.
    PubMed     Abstract available


    November 2020
  21. SONG Y, Wang M, Tong H, Tan Y, et al
    Plasma exosomes from endometrial cancer patients contain LGALS3BP to promote endometrial cancer progression.
    Oncogene. 2020 Nov 18. pii: 10.1038/s41388-020-01555.
    PubMed     Abstract available


    October 2020
  22. ZHANG Q, Zhou W, Yu S, Ju Y, et al
    Metabolic reprogramming of ovarian cancer involves ACSL1-mediated metastasis stimulation through upregulated protein myristoylation.
    Oncogene. 2020 Oct 20. pii: 10.1038/s41388-020-01516.
    PubMed     Abstract available


  23. RANZUGLIA V, Lorenzon I, Pellarin I, Sonego M, et al
    Serum- and glucocorticoid- inducible kinase 2, SGK2, is a novel autophagy regulator and modulates platinum drugs response in cancer cells.
    Oncogene. 2020;39:6370-6386.
    PubMed     Abstract available


  24. REN S, Gaykalova DA, Guo T, Favorov AV, et al
    HPV E2, E4, E5 drive alternative carcinogenic pathways in HPV positive cancers.
    Oncogene. 2020;39:6327-6339.
    PubMed     Abstract available


    September 2020
  25. XU Z, Li X, Li H, Nie C, et al
    Suppression of DDX39B sensitizes ovarian cancer cells to DNA-damaging chemotherapeutic agents via destabilizing BRCA1 mRNA.
    Oncogene. 2020 Sep 28. pii: 10.1038/s41388-020-01482.
    PubMed     Abstract available


    May 2020
  26. LI J, Alvero AB, Nuti S, Tedja R, et al
    CBX7 binds the E-box to inhibit TWIST-1 function and inhibit tumorigenicity and metastatic potential.
    Oncogene. 2020;39:3965-3979.
    PubMed     Abstract available


    March 2020
  27. HAYASHI T, Sano K, Aburatani H, Yaegashi N, et al
    Initialization of epithelial cells by tumor cells in a metastatic microenvironment.
    Oncogene. 2020;39:2638-2640.
    PubMed    


    January 2020
  28. ZHOU Y, Liu H, Wang J, Wang X, et al
    DeltaNp63alpha exerts antitumor functions in cervical squamous cell carcinoma.
    Oncogene. 2020;39:905-921.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Gynecology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: